Publication
Published papers
HOXB5 confers tamoxifen resistance in breast cancer cells and promotes tumor aggression and progression.
Kim CY, Kim YC, Oh JH†, and Kim MH†
Anticancer Research. 2021
Anticancer Research. 2021
NR4A1 regulates tamoxifen resistance by suppressing ERK signaling in ER-positive breast cancer.
Kim CY, Kim YC, Oh JH†, and Kim MH†
Cells, 2021
Cells, 2021
HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer
Kim CY, Kim YC, Oh JH†, and Kim MH†
Journal of Cancer. 2021
Journal of Cancer. 2021
Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer.
Oh JH, Lee J-Y, Kim KH, Kim CY, Jeong DS, Cho Y, Nam KT†, and Kim MH†
Cancer Letters. 2020
Cancer Letters. 2020
The LncRNA HOTAIRM1 promotes tamoxifen resistance by mediating HOXA1 expression in ER+ breast cancer cells.
Kim CY, Oh JH, Lee J-Y†, and Kim MH†
Journal of Cancer. 2020
Journal of Cancer. 2020
RAE1 mediated ZEB1 expression promotes epithelial-mesenchymal transition in breast cancer
Oh JH, Lee J-Y, Yu S, Cho Y, Hur S, Nam KT†, and Kim MH†
Scientific Reports. 2019
Scientific Reports. 2019